Get started
Author

Ferran Chuecos

Observed names: Chuecos Ferran, Chuecos, Ferran, F Chuecos
Institution: AstraZeneca (Spain)
OpenAlex ID: A5038136376
Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study
2013 · Jutta Beier, Anne-Marie Kirsten, et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 107
PDF
Characterisation and impact of reported and unreported exacerbations: results from ATTAIN
2014 · Paul W. Jones, Rosa Lamarca, et al. · European Respiratory Journal · 81
PDF
Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
2017 · Dave Singh, Anthony D. D’Urzo, et al. · Respiratory Research · 33
PDF
Meta-Analysis of the Efficacy of Ebastine 20 mg Compared to Loratadine 10 mg and Placebo in the Symptomatic Treatment of Seasonal Allergic Rhinitis
2005 · Paul Ratner, Meritxell Falqués, et al. · International Archives of Allergy and Immunology · 32
Aclidinium Bromide, a Long-Acting Antimuscarinic, Does Not Affect QT Interval in Healthy Subjects
2010 · Kenneth C. Lasseter, Jordi Aubets, et al. · The Journal of Clinical Pharmacology · 26
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
2019 · Dave Singh, Anthony D D'Urzo, et al. · International Journal of COPD · 21
PDF
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
2016 · Marc Miravitlles, Kenneth Chapman, et al. · International Journal of COPD · 20
The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies
2016 · Paul W. Jones, Nancy K. Leidy, et al. · Respiratory Research · 20
PDF
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
2016 · Lorcan McGarvey, Alyn H Morice, et al. · BMJ Open Respiratory Research · 19
PDF
Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study
2017 · Jutta Beier, Robert Mroz, et al. · International Journal of COPD · 11
PDF
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
2019 · Anthony D D'Urzo, Dave Singh, et al. · International Journal of COPD · 9
PDF
Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
2016 · Jadwiga A. Wedzicha, Alvar Agusti, et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 9
PDF
Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients
2015 · Marc Miravitlles, Esther Garcia Gil, et al. · European Respiratory Journal · 3
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity
2015 · Anthony D. D'Urzo, Dave Singh, et al. · European Respiratory Journal · 3
Effect of aclidinium bromide on exacerbations in patients with moderate-to-severe COPD: Pooled analysis of phase III studies
2014 · Jadwiga A. Wedzicha, Gavin C. Donaldson, et al. · European Respiratory Journal · 3
S51 Efficacy of Aclidinium Bromide Compared with Tiotropium and Placebo in Patients with Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1
2012 · Jutta Beier, Anne Marie Kirsten, et al. · Thorax · 3
PDF
The effect of twice-daily aclidinium bromide on cough and sputum in patients with COPD: Results from phase III studies
2014 · Lorcan McGarvey, Alyn H. Morice, et al. · European Respiratory Journal · 2
Improvement in COPD symptoms with aclidinium bromide vs placebo and tiotropium: A phase IIIb study
2013 · Jutta Beier, Anne-Marie Kirsten, et al. · European Respiratory Journal · 2
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
2017 · Dave Singh, Anthony D D'Urzo, et al. · European Respiratory Journal · 1
Efficacy and safety of aclidinium bromide vs placebo and tiotropium in COPD: A phase IIIb study
2013 · Jutta Beier, Anne-Marie Kirsten, et al. · European Respiratory Journal · 1
Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial
2021 · Robert A. Wise, Benjamin M. Scirica, et al. · Advances in Therapy
PDF
アクリジニウム/ホルモテロールによる慢性閉塞性肺疾患における臨床的に重要な悪化の減少【jst・京大機械翻訳】
2017 · Singh Dave, D D’Urzo Anthony, et al.
Additional file 1: of Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
2017 · Singh, Dave, D’Urzo, Anthony, et al. · Figshare
Reduction in clinically important deterioration in COPD with aclidinium/formoterol
2016 · Dave Singh, Anthony D. D'Urzo, et al. · European Respiratory Journal
Lungenfunktion unter Fixdosis-Kombination aus Aclidinium/Formoterol: Gepoolte Analyse aus zwei Phase-III-Studien über COPD
2016 · D Singh, A D'Urzo, et al. · Pneumologie
Works count: 37
Citation count: 406
H-index: 10
I10-index: 10
Year
Topic
Type